BANJA LUKA (Bosnia and Herzegovina), May 21 (SeeNews) – German generic drugs producer STADA will invest some 9.0 million euro ($14 million) in its Bosnian unit Hemofarm Banja Luka this and next year to triple its tablets output to 1.5 billion pieces per year, the government of Bosnia’s Serb Republic said.